Corvus Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Corvus Pharmaceuticals Inc
TickerCRVS
CIK #0001626971
CUSIP221015100
SectorLife Sciences - Pharmaceutical Preparations
Address863 Mitten Road Suite 102, Burlingame, CA 94010
Source [EDGAR]
CIK Filing 2011 - 2024
[0001626971] 10-K
[0001626971] 10-Q
[0001626971] 3
[0001626971] 4
[0001626971] 5
[0001626971] 8-K
[0001626971] D
[0001626971] SC 13D
[0001626971] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
CHI Advisors LLC Corvus Pharmaceuticals Inc [2023-02-13] 5.12
Integrated Core Strategies US LLC Corvus Pharmaceuticals Inc [2021-12-06] 4.5
Integrated Core Strategies US LLC Corvus Pharmaceuticals Inc [2021-10-22] 3.8
Venrock Healthcare Capital Partners II LP Corvus Pharmaceuticals Inc [2021-09-30] 8.1
Tang Capital Partners LP Corvus Pharmaceuticals Inc [2021-09-22] 8.8
EcoR1 Capital LLC Corvus Pharmaceuticals Inc [2021-05-11] 8.5
Price T Rowe Associates Inc /MD/ Corvus Pharmaceuticals Inc [2019-02-14] 6.7
Adams Street Partners LLC Corvus Pharmaceuticals Inc [2018-03-21] 15.5
Biotechnology Value Fund L P Corvus Pharmaceuticals Inc [2018-03-19] 3.2
Adams Street Partners LLC Corvus Pharmaceuticals Inc [2017-02-13] 13.0
FMR LLC Corvus Pharmaceuticals Inc [2016-08-10] 0.0
Miller Richard A MD Corvus Pharmaceuticals Inc [2016-04-08] 5.23
OrbiMed Advisors LLC Corvus Pharmaceuticals Inc [2016-04-01] 25.77
Novo A/S Corvus Pharmaceuticals Inc [2016-03-30] 15.5
Form 3/4/5 Filer 2011 - 2024
Grais Linda
Corvus Pharmaceuticals, Inc.
Miller Richard A MD
Jones William Benton
Lea LEIV
Morrison Scott W
Gould Terry P
Thompson Peter A.
Clark Ian T
Adams Street Partners LLC
Mitchell Edith P.
EcoR1 Capital, LLC
OrbiMed Advisors LLC
OrbiMed Capital GP V LLC
Mobasher Mehrdad
Novo Holdings A/S
Krognes Steve E.
Buggy Joseph J
Hunt Daniel W.
Verner Erik J.
Isaly Samuel D
Coloma Jason V
Moldt Peter
Form 13F Holdings
Firm Period DFND Voting Shares
OrbiMed Advisors LLC [2023-03-31] SOLE 6,943,654.0 6,943,654.0
Adams Street Partners LLC [2023-03-31] SOLE 3,275,616.0 3,275,616.0
CHI Advisors LLC [2023-03-31] DFND 2,339,402.0 2,339,402.0
Millennium Management LLC [2023-03-31] SOLE 2,029,423.0 2,029,423.0
BVF Inc/IL [2023-03-31] DFND 0.0 1,370,947.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,260,566.0
Discovery Capital Management LLC / CT [2023-03-31] SOLE 548,727.0 548,727.0
Renaissance Technologies LLC [2023-03-31] SOLE 293,932.0 506,032.0
Artal Group S.A. [2023-03-31] DFND 500,000.0 500,000.0
BlackRock Inc. [2023-03-31] SOLE 493,222.0 493,222.0
Geode Capital Management LLC [2023-03-31] DFND 297,800.0 297,800.0
Two Sigma Investments LP [2023-03-31] SOLE 204,047.0 204,047.0
Two Sigma Advisers LP [2023-03-31] SOLE 167,200.0 187,300.0
Bridgeway Capital Management LLC [2023-03-31] SOLE 159,300.0 159,300.0
Acadian Asset Management LLC [2023-03-31] DFND 131,771.0 131,771.0
State Street Corp [2023-03-31] DFND 112,603.0 112,603.0
Morgan Stanley [2023-03-31] DFND 0.0 100,159.0
Jackson Square Capital LLC [2023-03-31] SOLE 0.0 63,773.0
Northern Trust Corp [2023-03-31] DFND 58.0 61,668.0
Hikari Power Ltd [2023-03-31] DFND 49,959.0 49,959.0
LMR Partners LLP [2023-03-31] SOLE 30,000.0 30,000.0
Baader Bank Aktiengesellschaft [2023-03-31] SOLE 24,911.0 24,911.0
Commerce Bank [2023-03-31] SOLE 20,000.0 20,000.0
Virtu Financial LLC [2023-03-31] DFND 19,354.0 19,354.0
Tower Research Capital LLC (TRC) [2023-03-31] DFND 12,597.0 12,597.0
Wolverine Trading LLC [2023-03-31] DFND 0.0 12,500.0
UBS Group AG [2023-03-31] DFND 0.0 11,014.0
Mercer Global Advisors Inc /ADV [2023-03-31] SOLE 10,550.0 10,550.0
Envestnet Asset Management Inc [2023-03-31] SOLE 10,500.0 10,500.0
Susquehanna International Group LLP [2023-03-31] DFND 10,443.0 10,443.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com